Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing the new Tapestri scMRD Assay for AML. Learn More
X
Scientific presentation

Clonal evolution underlying clinical responses and relapses in subjects with IDH1-mutated AML treated with ivosidenib monotherapy or ivosidenib + azacitidine


Dylan Marchione, PhD
Description

At this year’s World CB & CDx conference held in Boston, Dylan Marchione, PhD, of Servier Pharmaceuticals presented data supporting the use of the Tapestri Platform in clinical development to elucidate clonal evolution patterns in patients with IDH1-mutated AML treated with combination therapy, TIBSOVO + azacitidine, as compared to monotherapy.



VIEW


Scientific presentation
Overview on Mission Bio’s Applications
Simone Formisano
Mission Bio EU Heme Symposium (2022)
Scientific presentation
Single Cell Core Facility Services at Josep Carreras Institute
Caterina Mata Garcia, PhD
Mission Bio EU Heme Symposium (2022)
Scientific presentation
EU Heme Symposium Panel Discussion
Manel Esteller, MD, PhD
Maria Paola Martelli, MD PhD, Renee Beekman, PhD
Ferran Nadeu, PhD
Mission Bio EU Heme Symposium (2022)
Scientific presentation
Monitoring of Leukemia Clones in B-cell Acute Lymphoblastic Leukemia at Diagnosis and During Treatment by Single-cell DNA Amplicon Sequencing
Sarah Meyers, PhD
Mission Bio EU Heme Symposium (2022)
REQUEST QUOTE